Anaeropharma Science

OverviewSuggest Edit

Anaeropharma Science is a biopharmaceutical company, established to pioneer the development of novel therapeutics to target such a hypoxic environment in solid cancers based on its proprietary platform technology, i-DPS (in situ Delivery and Production System) utilizing recombinant bifidobacterium. The company aims to leverage the recombinant bifidobacterium technology to create a new class of anti-cancer drugs.

TypePrivate
Founded2004
HQChiyoda City, JP
Websiteanaeropharma.co.jp

Latest Updates

Employees (est.) (Feb 2020)6

Key People/Management at Anaeropharma Science

Tetsuya Mishima

Tetsuya Mishima

President and CEO

Anaeropharma Science Office Locations

Anaeropharma Science has an office in Chiyoda City
Chiyoda City, JP (HQ)
Tower 201, 1-chōme-103 Kanda Jinbōchō
Show all (1)

Anaeropharma Science Financials and Metrics

Summary Metrics

Founding Date

2004

Anaeropharma Science total Funding

$13.2 m

Anaeropharma Science latest funding size

$13.20 m

Time since last funding

3 years ago

Anaeropharma Science investors

Anaeropharma Science's latest funding round in July 2017 was reported to be $13.2 m. In total, Anaeropharma Science has raised $13.2 m
Show all financial metrics

Anaeropharma Science Online and Social Media Presence

Embed Graph

Anaeropharma Science News and Updates

Anaeropharma Science unterzeichnet gemeinsame Forschungsvereinbarung mit Astellas zur Entwicklung neuartiger Anti-Tumor-Medikamente auf Grundlage von Bifidobacterium

TOKIO, 25. September 2018 /PRNewswire/ -- Wie Anaeropharma Science Inc. mit Sitz in Tokio (nachfolgend „Anaeropharma") am 25. September bekanntgab, haben Anaeropharma und Astellas Pharma Inc. mit Sitz in Tokio (nachfolgend „Astellas") eine gemeinsame Forschungsvereinbarung unterzeichnet....

Anaeropharma Science Blogs

Anaeropharma Science Signs Collaborative Research Agreement with Chugai on Creation of Novel Oncology Drugs Using Bifidobacterium

Anaeropharma Science Inc. headquartered in Tokyo (hereinafter “Anaeropharma”) announced on October 22 that Anaeropharma Science and Chugai Pharmaceutical Co., Ltd. headquartered in Tokyo (hereinafter “Chugai”) have concluded a collaborative research agreement concerning the creation of novel oncolog…

Anaeropharma Science Signs Collaborative Research Agreement with Astellas on Creation of Novel Anti-Tumor Drugs Using Bifidobacterium

Anaeropharma Science Inc. headquartered in Tokyo ( hereafter “Anaeropharma”) announced on September 25 that Anaeropharma and Astellas Pharma Inc. headquartered in Tokyo ( hereafter “Astellas”) have concluded a collaborative research agreement concerning the creation of novel anti-tumor drugs that ut…

Anaeropharma Science Frequently Asked Questions

  • When was Anaeropharma Science founded?

    Anaeropharma Science was founded in 2004.

  • Who are Anaeropharma Science key executives?

    Anaeropharma Science's key executives are Tetsuya Mishima.

  • How many employees does Anaeropharma Science have?

    Anaeropharma Science has 6 employees.

  • Who are Anaeropharma Science competitors?

    Competitors of Anaeropharma Science include NovaBay Pharmaceuticals, LGC Biosearch Technologies and Loxo Oncology.

  • Where is Anaeropharma Science headquarters?

    Anaeropharma Science headquarters is located at Tower 201, 1-chōme-103 Kanda Jinbōchō, Chiyoda City.

  • Where are Anaeropharma Science offices?

    Anaeropharma Science has an office in Chiyoda City.

  • How many offices does Anaeropharma Science have?

    Anaeropharma Science has 1 office.